XBIO_watchlistXBIO looks like it could be moving upwards just based on the bullish hammer after the flag which price compression may put this back on the upside... could move down and revert to mean or follow the fib...
−2.71USD
−4.13 MUSD
2.54 MUSD
1.25 M
About Xenetic Biosciences, Inc.
Sector
CEO
Jeffrey F. Eisenberg
Headquarters
Framingham
Website
Employees (FY)
4
Founded
2011
ISIN
US9840156023
FIGI
BBG0028WJXC0
Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.
XBIO target reached and now?XBIO target was reached but what now? (check last analysis)
The volume does show the are between the white lines are pretty accepted, I don´t think we should fall below again.
May be we consolidate a bit between until we break the upper line and confirm the next bull run.
But be aware of double t
$XBIO SIMPLE INSIDE BAR SQUEEZE SETUP!INSIDE BAR SQUEEZE PLAY
-TEXTBOOK PLAY
-SOMETIMES IS A FAKEOUT
-WATCH FOR VOLUME
-KEEP TREND AND PRICE ACTION ON WATCH
-SECURE THE BAG WHEN NECCARY
-NO GREED TAKE PROFITS!
XBIO short term targetXBIo is again growing but offers a lot of short opportunity. It should fall again back around $3.50.
$XBIO is gonna fall todayPupm&Dump trading strategy idea.
$XBIO is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $2,53;
stop-loss — $1,87;
take-profit — $2,86.
Do not view t
XBIO Parabolic Or New Massive Bull Trend?XBIO stock surged on its highest volume in months for no apparent reason. No news, no filings, and the most recent was the departure of Dr. Genkin from the Board. Obviously, the focus on low float penny stocks has been apparent in the stock market this week. XBIO could be the next iteration of that
XBIO: Breakout Confirmed, 35.21% Potential Profit!Description: XBIO is trending higher and in an uptrend meaning that highs are getting higher and lows are getting higher. The uptrend line on the chart and the Trending Band Indicator (which measures trend) supports the Long Position.
Stats:
1. Ideal buy range: $2 - $2.2
2. Take profit: $2.88
3. St
$XBIO: SmlCap play - Potential 45-105% upside from today's closesee easy and self explanatory boxes on chart for Entry, Exit and Stop loss zones. Never chase any stock.
Not for any recommendation, Just an Idea. Like it >> Click 👍/comment, and follow.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of XBIO is 4.20 USD — it has increased by 1.45% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Xenetic Biosciences, Inc. stocks are traded under the ticker XBIO.
Xenetic Biosciences, Inc. is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
XBIO stock is 5.53% volatile and has beta coefficient of 0.75. Check out the list of the most volatile stocks — is Xenetic Biosciences, Inc. there?
XBIO earnings for the last quarter are −0.69 USD per share, whereas the estimation was −1.12 USD resulting in a 38.39% surprise. The estimated earnings for the next quarter are −0.76 USD per share. See more details about Xenetic Biosciences, Inc. earnings.
Xenetic Biosciences, Inc. revenue for the last quarter amounts to 611.17 K USD despite the estimated figure of 460.00 K USD. In the next quarter revenue is expected to reach 670.00 K USD.
Yes, you can track Xenetic Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
XBIO stock has fallen by 5.83% compared to the previous week, the month change is a 0.24% fall, over the last year Xenetic Biosciences, Inc. has showed a 10.64% decrease.
XBIO net income for the last quarter is −1.17 M USD, while the quarter before that showed −1.06 M USD of net income which accounts for −10.98% change. Track more Xenetic Biosciences, Inc. financial stats to get the full picture.
Today Xenetic Biosciences, Inc. has the market capitalization of 6.38 M, it has increased by 5.92% over the last week.
No, XBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, XBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Xenetic Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 4.00 employees. See our rating of the largest employees — is Xenetic Biosciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Xenetic Biosciences, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Xenetic Biosciences, Inc. stock shows the neutral signal. See more of Xenetic Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Xenetic Biosciences, Inc. EBITDA is −4.52 M USD, and current EBITDA margin is −177.79%. See more stats in Xenetic Biosciences, Inc. financial statements.